streptococcu
pneumonia
main
caus
diseas
mening
pneumonia
sepsi
especi
children
old
peopl
due
costli
antibiot
treatment
increas
resist
pneumococcu
develop
higheffici
protect
vaccin
pathogen
urgent
need
although
pneumonia
polysaccharid
vaccin
ppv
pneumonia
conjug
vaccin
pcv
effici
pneumococc
vaccin
children
adult
group
serotyp
replac
pneumonia
strain
caus
reduct
efficaci
vaccin
overcom
aforesaid
drawback
epitopebas
vaccin
introduc
relev
altern
previou
research
epitop
vaccin
design
base
immunodomin
epitop
pspa
cbpa
antigen
cellular
stimul
phtd
piua
humor
stimul
low
immunogen
main
disadvantag
epitop
vaccin
current
studi
appli
coiledcoil
selfassembl
structur
develop
vaccin
recent
selfassembl
peptid
nanoparticl
sapn
gain
much
attent
field
vaccin
develop
due
multival
selfadjuvant
biocompat
size
similar
pathogen
regard
final
design
vaccin
compris
cytotox
lymphocyt
ctl
epitop
pspa
cbpa
helper
lymphocyt
htl
epitop
phtd
piua
pentam
trimmer
oligomer
domain
form
coiledcoil
selfassembl
scaffold
diphtheria
toxoid
dtd
univers
thelper
fuse
appropri
linker
four
differ
arrang
base
order
abovement
compart
construct
model
valid
find
structur
structur
physicochem
immunoinformat
analys
final
vaccin
construct
repres
vaccin
could
stimul
potent
immun
respons
pneumonia
howev
potenc
approv
via
variou
vivo
vitro
immunolog
test
streptococcu
pneumonia
lead
caus
bacteri
diseas
sepsi
mening
pneumonia
due
high
mortal
rate
global
burden
diseas
especi
children
elderli
nation
institut
health
nih
paid
attent
pneumococc
diseas
recent
year
highcost
antibiot
therapi
increas
resist
pneumococcu
current
antibiot
suggest
vaccin
pneumonia
best
method
prevent
diseas
accord
center
diseas
control
prevent
cdc
report
http
wwwcdcgovpneumococcalabout
preventionhtml
pneumococc
vaccin
develop
mainli
base
surfac
antigen
includ
immunogen
protein
carbohydr
streptococcu
pneumonia
polysaccharid
vaccin
ppv
pneumonia
conjug
vaccin
carbohydratebas
vaccin
stimul
serotypespecif
immun
pneumonia
polysaccharid
vaccin
still
appli
elderli
routin
vaccin
children
countri
howev
vaccin
cover
serotyp
especi
elderli
next
gener
vaccin
could
cover
pneumonia
serotyp
howev
serotyp
replac
strategi
pneumococc
infect
caus
reduc
efficaci
group
vaccin
thu
necessari
design
effici
novel
vaccin
epitopebas
pneumococc
vaccin
last
gener
vaccin
pipelin
context
pneumococc
surfac
http
receiv
august
receiv
revis
form
septemb
accept
septemb
protein
pspa
locat
surfac
bacteria
cholin
bind
protein
cbpa
crucial
protect
surfac
antigen
introduc
vaccin
candid
anoth
import
vaccin
candid
pneumococc
histidin
triad
pht
protein
famili
includ
phte
phtd
conserv
member
pht
express
pneumococc
pathogenesi
pneumococc
protein
shown
potenti
effici
vaccin
candid
need
full
virul
pneumonia
anim
model
pneumococc
iron
abc
transport
includ
two
lipoprotein
compon
piua
piaa
gener
major
epitopebas
vaccin
caus
induct
cellular
orand
humor
immun
well
offer
safer
easyproduc
altern
prevent
diseas
howev
low
immunogen
main
disadvantag
type
vaccin
solv
problem
sever
method
use
enhanc
immunogen
epitop
vaccin
like
prescrib
multipl
dose
vaccin
ad
immunostimulatori
agent
adjuv
vaccin
recent
strategi
appli
selfassembl
peptid
motif
includ
betasheet
coiledcoil
structur
epitop
vaccin
besid
abovement
strategi
incorpor
univers
thelper
epitop
like
diphtheria
toxoid
dtd
vaccin
enhanc
vaccin
efficaci
dtd
essenti
compon
diphtheria
vaccin
wide
use
univers
thelper
case
low
efficaci
epitop
peptidebas
vaccin
may
accord
fast
extracellular
degrad
rapid
distribut
inject
site
ineffici
uptak
antigenpres
cell
apc
sever
investig
shown
link
epitop
vaccin
certain
carrier
eg
polymer
lipid
nanostructur
develop
efficaci
vaccin
via
confer
aforesaid
obstacl
context
design
epitop
vaccin
base
selfassembl
peptid
nanoparticl
sapn
scaffold
act
antigenpres
system
novel
strategi
moreov
sapn
vaccin
selfadjuvant
without
toxic
regard
bypass
low
immunogen
epitop
peptid
vaccin
studi
epitop
select
piua
phtd
antigen
epitop
chosen
pspa
cbpa
antigen
pneumonia
moreov
dtd
determin
univers
thelper
compart
select
epitop
insert
pentam
trimer
oligomer
domain
construct
selfassembl
structur
addit
segment
fuse
appropri
linker
immunoinformat
structur
evalu
design
vaccin
show
induc
proper
immun
pneumonia
howev
experiment
immunolog
test
confirm
efficaci
vaccin
first
step
amino
acid
sequenc
pspa
access
cbpa
access
phtd
piua
access
streptococcu
pneumonia
retriev
nation
center
biotechnolog
inform
ncbi
wwwncbinlmnihgov
fasta
format
pspa
cbpa
appli
select
cytotox
lymphocyt
ctl
epitop
phtd
piua
use
selectin
helper
epitop
moreov
dtd
employ
univers
thelper
moreov
gener
selfassembl
vaccin
pentam
trimer
oligomer
domain
respect
form
coiledcoil
ad
vaccin
construct
next
step
part
vaccin
includ
epitop
epitop
univers
thelper
pentam
trimer
oligomer
domain
fuse
proper
amino
acid
linker
accord
order
vaccin
part
four
differ
construct
built
schemat
structur
four
design
vaccin
construct
shown
fig
instabl
index
theoret
isoelectr
point
pi
grand
averag
hydropath
gravi
extinct
coeffici
estim
halflif
aliphat
index
design
vaccin
construct
evalu
protparam
server
http
webexpasyorg
protparam
solubl
differ
protein
predict
proteinsol
server
http
proteinsolmanchesteracuk
proteinsol
employ
fast
sequencebas
method
predict
solubl
protein
base
avail
data
escherichia
coli
protein
solubl
solubl
valu
greater
defin
higher
solubl
averag
solubl
e
coli
protein
addit
fold
propens
net
charg
per
amino
acid
profil
calcul
along
sequenc
solpro
http
scratch
proteomicsicsuciedu
anoth
server
use
solubl
predict
base
overexpress
e
coli
predict
method
base
twostag
svm
architectur
accuraci
server
secondari
structur
protein
sequenc
defin
raptorxproperti
http
predict
raptorxproperti
server
evalu
structureproperti
protein
sequenc
via
templatefre
method
server
secondari
structur
ss
solvent
access
acc
input
sequenc
predict
power
machin
learn
model
call
deep
convolut
neural
field
deepcnf
accuraci
ss
accuraci
ss
accuraci
solvent
access
obtain
server
itass
softwar
http
zhanglabccmbmedumicheduitass
galaxytbm
softwar
http
galaxyseoklaborg
softwar
use
gener
structur
four
design
vaccin
construct
base
obtain
result
best
model
select
accord
critic
assess
method
protein
structur
predict
data
itass
rank
top
server
autom
protein
structur
model
itass
predict
method
includ
four
success
step
thread
secondari
structur
project
templat
select
structur
fragment
assembl
appli
modifi
replicaexchang
mont
carlo
simul
method
select
model
employ
cluster
structur
decoy
refin
fragmentguid
molecular
dynam
simul
fgmd
modrefin
lastli
structurebas
biolog
function
annot
itass
introduc
cscore
confid
score
assess
overal
qualiti
model
ucsf
chimera
discoveri
studio
softwar
employ
visual
model
protein
galaxytbm
templatebas
model
predict
protein
structur
sequenc
experiment
structur
homolog
protein
avail
templat
refin
loop
terminu
region
ab
initio
model
structur
refin
galaxyrefin
server
http
galaxyseoklaborgcgibinsubmitcgi
typerefin
server
refin
protein
model
via
loop
model
overal
structur
relax
perform
molecular
dynam
simul
server
among
best
avail
web
server
structur
refin
accord
assess
refin
structur
compar
model
valid
errat
server
http
ramachandran
plot
assess
http
mordredbioccamacuk
rapperrampagephp
http
servicesmbiucla
prosaweb
http
prosaservicescam
sbgacat
overal
qualiti
score
known
indic
prosaweb
calcul
analyz
atom
coordin
model
prosaweb
zscore
repres
plot
contain
zscore
experiment
identifi
structur
avail
pdb
ramachandran
plot
valid
protein
model
evalu
residuebyresidu
stereo
chemic
qualiti
model
errat
server
specif
atom
interact
consid
determin
correct
incorrect
defin
region
protein
structur
plo
valu
error
function
versu
posit
slide
window
analyz
comparison
statist
databas
reliabl
highresolut
crystallographi
structur
galaxyhomom
server
http
galaxyseoklaborghomom
appli
predict
protein
homooligom
structur
monom
structur
subunit
either
sequenc
pdb
monom
use
input
server
accord
access
suitabl
oligom
templat
predict
five
homooligom
structur
three
strategi
sequenc
similaritybas
approach
structur
similaritybas
approach
ab
initio
dock
approach
recent
develop
model
refin
method
galaxyloop
galaxyrefinecomplex
integr
galaxyhomom
improv
qualiti
model
perform
server
better
access
method
verifi
benchmark
set
model
protein
done
predict
conform
bcell
epitop
discotop
server
http
wwwcb
dtudkservicesdiscotopewa
appli
server
final
score
calcul
two
method
contact
number
deriv
surfac
access
b
novel
epitop
partial
amino
acid
score
default
threshold
sensit
specif
server
respect
antigenpro
server
http
scratchproteomicsicsuciedu
vaxijen
server
http
wwwddgpharmfacnet
vaxijenvaxijenvaxijenhtml
appli
antigen
analysi
antigenpro
sequencebas
alignmentfre
pathogenindepend
predictor
accuraci
moreov
vaxijen
appli
alignmentindepend
method
base
auto
crosscovari
transform
protein
sequenc
uniform
vector
princip
amino
acid
featur
accuraci
server
rang
depend
select
target
organ
bacteria
tumor
fungal
parasit
viru
two
server
allergenfp
http
ddgpharmfacnet
allergenfp
algpr
http
wwwimtechresin
raghavaalgpr
use
evalu
allergen
allergenfp
discrimin
allergen
nonallergen
alignmentindepend
descriptorbas
fingerprint
method
use
descriptor
hydrophob
size
rel
abund
helix
betastrand
protein
sensit
specif
accuraci
server
algpr
employ
combin
differ
approach
svmc
igeepitop
arp
blast
mast
predict
allergen
server
accuraci
estim
threshold
md
simul
known
uniqu
techniqu
better
understand
biolog
system
use
tool
recent
expand
significantli
work
md
simul
carri
monomer
chain
homodim
structur
chosen
dock
process
galaxyhomom
server
md
simul
perform
intend
system
use
gromac
packag
forc
field
system
solvat
triclin
box
water
molecul
minim
distanc
edg
box
moreov
concentr
mm
nacl
physiolog
condit
ad
neutral
system
particl
mesh
ewald
pme
method
linc
algorithm
use
calcul
longrang
electrostat
interact
constrain
bond
respect
nonbond
cutoff
use
firstli
prepar
system
minim
use
steepest
descent
algorithm
first
equilibr
step
done
nvt
ensembl
k
ps
step
follow
ps
npt
equilibr
run
bar
pressur
k
temperatur
veloc
rescal
ps
parrinellorahman
barostat
algorithm
p
ps
use
temperatur
pressur
coupl
respect
final
md
product
run
perform
ns
equival
condit
bar
k
time
step
fs
appli
output
file
save
everi
two
ps
analys
accord
previou
studi
final
helper
epitop
wqtwnakwdqwsndwnawesdwqawkddwaewralwm
trimer
sequenc
rlllrler
ealealarfvanlsmrla
rnesr
chosen
selfassembl
motif
accord
sequenc
ctl
epitop
pspa
cbpa
helper
epitop
piua
phtd
follow
sequenc
design
fig
tabl
theoret
pi
number
amino
acid
estim
protein
halflif
mammalian
yeast
e
coli
aliphat
index
gravi
stabil
solubl
design
structur
shown
tabl
secondari
structur
element
solvent
access
disord
posit
vaccin
construct
predict
raptorx
tabl
moreov
detail
predict
result
shown
fig
four
differ
arrang
design
sequenc
selfassembl
epitop
peptid
vaccin
candid
consist
pspa
piua
linker
pentam
trimmer
structur
univers
helper
dtd
structur
four
design
vaccin
construct
model
itass
galaxyweb
softwar
galaxyweb
itass
provid
five
two
model
respect
sequenc
structur
refin
galaxyrefin
final
refin
structur
compar
best
model
valid
errat
server
ramachandran
plot
prosaweb
result
present
supplementari
tabl
tabl
accord
galaxyweb
result
select
addit
base
itass
result
h
e
c
stand
alphahelix
betasheet
coil
respect
b
b
e
stand
buri
medium
expos
residu
respect
detail
predict
result
secondari
structur
predict
ss
alphahelix
betasheet
coil
b
relev
solvent
access
acc
divid
three
state
cutoff
valu
three
state
equal
distribut
buri
less
expos
larger
medium
expos
amino
acid
solvent
evalu
secondari
structur
chosen
final
obtain
galaxyweb
select
best
model
follow
step
tabl
homooligom
protein
predict
galaxyhomom
five
homooligom
structur
predict
given
oligomer
state
tabl
base
dock
result
structur
protein
possess
best
score
dock
score
structur
tabl
afterward
best
model
subject
refin
process
final
initi
homom
model
bestrefin
homom
model
valid
ramachandran
plot
prosaweb
qualiti
protein
geometri
evalu
appli
ramachandran
plot
verifi
prosa
zscore
primari
model
residu
locat
favor
allow
outlier
region
respect
wherea
refin
model
residu
place
favor
allow
outlier
region
respect
verifi
result
show
initi
model
residu
averag
score
refin
model
verifi
score
prosaweb
z
score
initi
model
reach
final
model
conform
bcell
epitop
play
signific
role
humor
immun
thu
tertiari
structur
final
vaccin
exploit
input
conform
epitop
predict
discotop
bcell
epitop
residu
identifi
total
residu
discotop
score
threshold
shown
tabl
probabl
whole
vaccin
antigen
estim
antigenpro
vaxijen
threshold
base
allergenfp
result
vaccin
probabl
nonallergen
addit
algpr
show
protein
nonallergen
ensur
condit
wellcontrol
md
simul
import
paramet
evalu
analyz
result
regard
pressur
temperatur
densiti
energi
valu
assay
obtain
valu
paramet
indic
md
simul
done
correctli
firstli
analysi
md
trajectori
perform
monomer
system
rootmeansquar
deviat
rmsd
paramet
evalu
investig
stabil
protein
chain
throughout
md
simul
seen
fig
rmsd
plot
backbon
atom
protein
chain
show
signific
increas
ns
reach
steadyst
rest
simul
time
sinc
rmsd
paramet
determin
flexibl
rigid
region
protein
chain
rootmeansquar
fluctuat
rmsf
valu
residu
assay
well
residu
nand
ctermin
region
show
high
fluctuat
fig
fewer
intramolecular
interact
residu
neighbor
residu
show
high
mobil
md
simul
moreov
residu
region
protein
endur
high
fluctuat
well
major
residu
place
linker
thelper
region
side
chain
residu
expos
solvent
molecul
also
establish
intramolecular
interact
residu
md
simul
time
radiu
gyrat
rg
protein
measur
compact
paramet
estim
follow
mass
atom
r
posit
atom
respect
center
mass
molecul
chang
r
g
valu
monomer
chain
present
fig
clear
displac
rmsd
rmsf
plot
led
decreas
rg
valu
md
simul
accord
aforesaid
equat
decreas
rg
valu
indic
reduct
distanc
atom
mass
center
protein
protein
chain
fold
time
superimposit
initi
configur
obtain
structur
end
md
simul
time
confirm
trend
fig
second
step
trajectori
analysi
done
homodim
system
firstli
rmsd
paramet
evalu
backbon
atom
two
protein
chain
chain
suitabl
stabil
md
simul
although
chain
slightli
stabl
reach
steadi
state
ns
fig
rmsf
plot
chain
almost
similar
although
residu
chain
b
endur
littl
fluctuat
chain
residu
protein
chain
show
fluctuat
homodim
system
comparison
monomer
system
especi
pentam
trimer
region
neighbor
fig
rg
paramet
also
measur
chain
md
simul
accord
fig
rg
valu
chain
decreas
throughout
ns
md
simul
although
suffer
fluctuat
time
howsoev
rg
valu
chain
b
increas
tabl
highscor
model
obtain
four
design
sequenc
galaxyweb
server
first
half
simul
time
rg
plot
chain
shown
decreas
trend
rest
simul
time
fig
fact
md
simul
prepar
suitabl
opportun
two
protein
chain
get
best
configur
word
tri
stabl
conform
time
rmsd
rmsf
rg
plot
chain
b
indic
toler
displac
order
improv
configur
interact
rel
chain
number
hydrogen
bond
also
evalu
chain
chain
b
md
simul
time
seen
fig
endur
fluctuat
ns
final
reach
steadi
state
obvious
obtain
structur
end
simul
time
hydrogen
bond
comparison
initi
structur
distanc
mass
center
two
protein
chain
homodim
system
also
measur
md
simul
time
fig
obviou
distanc
decreas
significantli
ns
almost
stabl
ns
similar
trend
fig
e
show
distanc
center
mass
two
protein
chain
affect
number
hydrogen
bond
two
chain
solvent
access
surfac
sasa
paramet
also
measur
md
simul
fig
hydrophil
sasa
present
epitop
part
protein
chain
wherea
hydrophob
sasa
shown
pentam
trimer
part
increas
trend
hydrophil
sasa
valu
epitop
part
fig
hydrophob
sasa
valu
pentam
trimer
part
indic
epitop
part
prefer
interact
solvent
molecul
ns
md
simul
pentam
trimer
part
inclin
establish
hydrophob
interact
cours
time
fig
eventu
final
snapshot
homodim
system
end
simul
superimpos
initi
structur
obtain
dock
process
accord
fig
structur
system
chang
significantli
md
simul
protein
fold
happen
time
achiev
sustain
state
accord
nih
report
streptococcu
pneumonia
still
one
main
sourc
morbid
mortal
worldwid
especi
children
elderli
categor
high
burden
diseas
capsular
polysaccharid
cp
recogn
import
virul
factor
pneumonia
moreov
base
cpss
pneumonia
categor
distinct
serotyp
ten
common
serotyp
main
reason
pediatr
pneumococc
infect
worldwid
context
antibiot
therapi
common
medic
fight
bacteri
infect
lead
emerg
antibiot
resist
pneumonia
strain
regard
design
effici
prevent
vaccin
ration
choic
recent
countri
child
elderli
pneumococc
vaccin
ad
nation
immun
program
ppv
pcv
pneumococc
vaccin
avail
market
could
prevent
individu
differ
type
pneumococc
diseas
case
serotyp
replac
caus
failur
vaccin
complic
highcost
pcv
product
caus
vaccin
becom
unafford
especi
develop
countri
strategi
overcom
serotyp
replac
phenomena
firstli
addit
new
pneumococc
serotyp
eg
approch
current
phase
clinic
trial
second
approach
employ
wholecel
pneumococc
vaccin
method
attenu
inactiv
pathogen
use
appropri
altern
polysaccharidebas
vaccin
appli
pneumococc
protect
antigen
vaccin
construct
sever
conserv
protein
among
differ
pneumonia
serotyp
surfac
protein
pspa
cbpa
phtd
regard
previou
immunoinformat
studi
immunodomin
epitop
select
four
antigen
pspa
cbpa
phtd
piua
recent
epitopebas
vaccin
introduc
safer
altern
previou
type
vaccin
howev
suffer
disadvantag
low
immunogen
along
low
immunogen
peptid
vaccin
variabl
immunodomin
region
antigen
among
differ
serotyp
anoth
obstacl
design
effici
peptidebas
pneumococc
vaccin
suitabl
conserv
epitop
select
vaccin
would
high
popul
coverag
mentionedabov
low
immunogen
one
key
drawback
epitopebas
peptid
vaccin
overcom
issu
sever
approach
employ
incorpor
univers
thelper
epitop
vaccin
one
ration
strategi
enhanc
immunogen
previou
studi
recommend
diphtheria
toxoid
dtd
contain
univers
epitop
human
cell
residu
tetanu
toxoid
residu
dtd
context
okita
bm
et
al
show
dtd
peptid
residu
recogn
toxoidsensit
subject
regard
sequenc
select
univers
thelper
epitop
studi
efficaci
nanovaccin
confirm
differ
investig
includ
influenza
nanovaccin
chitosan
nanoparticl
influenza
viru
chaitosanformul
polyepitop
vaccin
pulmonari
mycobacteri
anoth
import
approach
increas
immunogen
peptid
vaccin
use
selfassembl
peptid
structur
includ
alpha
helic
beta
sheet
motif
obtain
natur
de
novo
structur
coiledcoil
biostructur
motif
common
scaffold
construct
sapn
vaccin
coiledcoil
motif
due
high
stabil
welldefin
structur
gain
attent
develop
sapn
vaccin
recent
year
uniqu
character
sapn
includ
biodegrad
biocompat
size
similar
pathogen
selfadjuvant
contain
repetit
structur
propos
promin
structur
design
epitopebas
peptid
vaccin
sapn
monom
subunit
oligomer
form
nanoparticl
contain
two
coiledcoil
domain
fuse
togeth
proper
linker
abl
oligomer
consequ
form
nanoparticl
context
sapn
format
mechan
two
coiledcoil
domain
pentamer
coiledcoil
deriv
ntermin
peptid
cartilag
oligomer
matrix
protein
trimer
coiledcoil
made
de
novo
design
ctermin
leucin
zipper
peptid
link
two
glycin
residu
form
higherord
nanoparticl
domain
selfassembl
combin
hydrophob
electrostat
interact
exist
within
residu
coiledcoil
domain
recent
year
differ
sapnbas
vaccin
design
evalu
variou
pathogen
includ
toxoplasma
gondii
human
immunodefici
virus
hiv
plasmodium
falciparum
sever
acut
respiratori
syndrom
sar
coronaviru
although
chen
et
al
studi
show
trival
antigen
combin
yln
protect
peptid
epitop
cbpa
fragment
pspa
epitop
vaccin
elicit
strong
broad
protect
divers
pneumococc
challeng
model
nt
report
product
epitopebas
sapn
vaccin
pneumonia
studi
first
time
antigen
bcell
epitop
ad
either
n
c
termin
end
gene
encod
monom
way
tcell
epitop
incorpor
vaccin
construct
activ
humor
cellular
arm
immun
system
besid
trimmer
pentam
domain
use
scaffold
sapn
fig
select
tand
bcell
epitop
fuse
monom
proper
linker
appli
linker
enhanc
proteasomemedi
cleavag
bind
tap
transport
process
play
role
helic
linker
increas
immunogen
vaccin
construct
physicochem
immunolog
properti
peptid
vaccin
evalu
differ
comput
tool
indic
structur
stabl
antigen
nonallergen
protein
popul
averag
scale
solubl
valu
queri
sol
proteinsol
server
queri
sol
greater
predict
high
solubl
protein
therefor
shown
tabl
select
protein
solubl
queri
sol
result
also
confirm
solpro
aliphat
index
protein
show
protein
thermost
instabl
index
protein
less
show
protein
stabl
test
tube
gravi
index
vaccin
present
protein
effici
interact
water
four
differ
arrang
vaccin
design
tabl
afterward
model
refin
variou
server
achiev
highqual
model
among
model
best
model
chosen
valid
ramachandran
plot
errat
verifi
prosaweb
server
highqual
model
appli
identif
conform
bcell
epitop
dock
process
accord
galaxyhomom
dock
score
subunit
best
number
subunit
protein
howev
best
model
refin
subject
md
simul
studi
accord
result
discotop
server
final
model
vaccin
conform
bcell
epitop
residu
tabl
confirm
vaccin
highli
potent
stimul
humor
immun
studi
secondari
structur
expos
amino
acid
solvent
demonstr
bcell
epitop
region
final
construct
highli
expos
solvent
trimmer
pentam
region
fig
conclud
pentam
trimmer
segment
locat
core
region
vaccin
epitop
part
locat
surfac
oligom
addit
evalu
solvent
access
surfac
sasa
paramet
measur
md
simul
fig
indic
epitop
part
prefer
interact
solvent
molecul
hydrophil
part
ns
md
simul
pentam
trimmer
part
inclin
establish
hydrophob
interact
time
evalu
r
g
valu
md
simul
indic
decreas
rg
valu
mean
decreas
distanc
atom
center
mass
protein
confirm
protein
chain
fold
time
howev
superimposit
initi
configur
end
simul
time
md
simul
confirm
stabil
design
monomer
chain
ns
md
simul
time
hand
homodim
structur
chosen
dock
process
show
appropri
stabil
cours
time
well
obtain
best
posit
rel
two
protein
chain
homodim
structur
tri
establish
stabl
intermolecular
interact
get
better
configur
md
simul
time
studi
order
design
selfassembl
peptid
nanovaccin
pneumonia
immunodomin
epitop
select
pspa
cbpa
piua
phtd
pneumonia
antigen
dtd
thelper
incorpor
vaccin
increas
immunogen
vaccin
moreov
pentam
trimer
oligomer
domain
coiledcoil
selfassembl
structur
employ
vaccin
construct
sum
studi
differ
strategi
appli
develop
protect
sapn
vaccin
pneumonia
howev
potenc
design
vaccin
confirm
via
differ
vitro
vivo
immunolog
assay
potenti
conflict
interest
report
author
author
wish
thank
shiraz
univers
medic
scienc
support
conduct
research
fig
superimposit
dock
model
homodim
structur
chain
chain
b
shown
cyan
magenta
respect
structur
obtain
end
md
simul
time
chain
chain
b
shown
blue
red
respect
